Navigation Links
'Glow-in-the-dark' red blood cells made from human stem cells
Date:8/24/2009

Victorian stem cell scientists from Monash University have modified a human embryonic stem cell (hESC) line to glow red when the stem cells become red blood cells.

The modified hESC line, ErythRED, represents a major step forward to the eventual aim of generating mature, fully functional red blood cells from human embryonic stem cells.

The research, conducted by a team led by Professors Andrew Elefanty and Ed Stanley at the Monash Immunology and Stem Cell Laboratories that included scientists at the Murdoch Children's Research Institute, was published in today's issue of the prestigious journal, Nature Methods.

The work, funded by the Australian Stem Cell Centre (ASCC), will help scientists to track the differentiation of embryonic stem cells into red blood cells.

Whilst hESCs have the potential to turn into any cell type in the body, it remains a scientific challenge to reliably turn these stem cells into specific cell types such as red blood cells. The development of the ErythRED embryonic stem cell line, which fluoresces red when haemoglobin genes are switched on, is an important development that will help researchers to optimise the conditions that generate these cells.

Professor Joe Sambrook, Scientific Director of the ASCC said that "The elegant work of the Elefanty-Stanley group unlocks the entrance to the long sought and elusive differentiation pathway that leads to expression of adult haemoglobin genes"

"Not only will the ErythRED cell line lead to more efficient creation of red blood cells from human embryonic stem cells, but these cells are a crucial tool for monitoring the behaviour of the cells when transplanted into animal models" said Professor Andrew Elefanty.


'/>"/>

Contact: Samantha Blair
Samantha.Blair@adm.monash.edu.au
61-399-034-841
Monash University
Source:Eurekalert

Page: 1

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. Right breakfast bread keeps blood sugar in check all day
3. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
4. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
5. Folic acid lowers blood arsenic levels in Bangladesh
6. Study reveals a key to blood vessel growth and possible drug target
7. Expecting an afternoon nap can reduce blood pressure
8. MIT: blood may help us think
9. Immune cells promote blood vessel formation in mouse endometriosis
10. Elevated nitric oxide in blood is key to high altitude function for Tibetans
11. Fine-tuning lasers to destroy blood-borne diseases like AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):
(Date:5/15/2017)... ... May 15, 2017 , ... Tunnell Consulting announced that Julia ... Key Role of Specifications in Process Validation,” at the Process Validation Summit 2017, ... bring together leaders from the pharmaceutical and biotech industries to explore processes, strategies and ...
(Date:5/15/2017)... Glendale, Calif. (PRWEB) , ... May 15, 2017 ... ... with today’s launch of ELEVATE Advanced Lift Contouring Cream, a gravity-shattering cream with ... , “We’re thrilled to bring the Advanced Lift Contouring Cream to ...
(Date:5/15/2017)...  IBM (NYSE: IBM ) scientists have ... DNA molecules with the potential to efficiently reveal ... technology complements the IBM Research,s "lab-on-a-chip" nanoDLD ... and which may also contain biomarkers for disease ... of diamond shaped micropillars 1 to pre-stretch ...
(Date:5/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... investigational treatment for the prevention of episodic and ... Phase 3 studies (EVOLVE-1, EVOLVE-2 and REGAIN) demonstrating ... migraine headache days compared to placebo at both ... from these three studies bring us one step ...
Breaking Biology Technology: